USRE36701EExpiredUtilityPatentIndex 52

Coronary heart disease treated with oestradiol

Assignee: STERIX LTDPriority: Jul 15, 1993Filed: Apr 29, 1998Granted: May 16, 2000

Est. expiryJul 15, 2013(expired)· nominal 20-yr term from priority

Inventors:COLLINS PETER

A61K 31/565

PatentIndex Score

Cited by

References

Claims

Abstract

Use of 17β-oestradiol in the treatment of coronary heart disease.

Claims

exact text as granted — not AI-modified

What is claimed is: 
     
       1. A method for the treatment of myocardial ischaemia which results from coronary heart disease, which comprises administration to a patient of an effective amount of 17β-oestradiol. 
     
     
       2. The method of claim 1, wherein said patient is a post-menopausal woman. 
     
     
       3. A method of treatment of myocardial ischaemia which results from coronary heart disease, which comprises the steps of: diagnosing coronary heart disease in a patient; and then administering to said patient an effective amount of 17β-oestradiol. .Iadd.4. A method for the treatment of myocardial ischaemia from coronary heart disease, which comprises administration to a patient of an effective amount of an oestrogen..Iaddend..Iadd.5. The method of claim 4 wherein said patient is a post-menopausal woman..Iaddend..Iadd.6. A method of treatment of myocardial ischaemia from coronary heart disease, which comprises the steps of:   diagnosing coronary heart disease in a patient; and then   administering to said patient an effective amount of an oestrogen..Iaddend.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.